Scott Fidel
Stock Analyst at Stephens & Co.
(1.82)
# 3,127
Out of 4,876 analysts
184
Total ratings
40%
Success rate
5.39%
Average return
Main Sectors:
Top Industries:
Stocks Rated by Scott Fidel
| Stock | Action | Price Target | Current | Upside | Ratings | Updated | |
|---|---|---|---|---|---|---|---|
| ARDT Ardent Health | Reiterates: Overweight | $21 | $13.29 | +58.07% | 5 | May 20, 2025 | |
| ADUS Addus HomeCare | Reiterates: Overweight | $142 | $114.87 | +23.62% | 12 | Mar 12, 2025 | |
| PNTG The Pennant Group | Reiterates: Overweight | $38 | $28.88 | +31.58% | 18 | Mar 11, 2025 | |
| AMED Amedisys | Reiterates: Equal-Weight | $101 | $97.97 | +3.09% | 13 | Mar 4, 2025 | |
| UHS Universal Health Services | Maintains: Equal-Weight | $210 → $223 | $177.43 | +25.68% | 10 | Feb 28, 2025 | |
| ALHC Alignment Healthcare | Reiterates: Overweight | $17 | $13.80 | +23.19% | 5 | Jan 2, 2025 | |
| CNC Centene | Maintains: Equal-Weight | $75 → $73 | $53.57 | +36.27% | 9 | Dec 13, 2024 | |
| UNH UnitedHealth Group | Maintains: Overweight | $605 → $675 | $302.62 | +123.05% | 22 | Dec 5, 2024 | |
| PACS PACS Group | Maintains: Overweight | $48 → $31 | $12.85 | +141.25% | 4 | Nov 18, 2024 | |
| CI The Cigna Group | Reiterates: Overweight | $410 | $330.00 | +24.24% | 12 | Nov 1, 2024 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintains: Overweight | $163 → $167 | $153.79 | +8.59% | 9 | Oct 28, 2024 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Initiates: Overweight | $21 | $21.18 | -0.83% | 1 | Oct 22, 2024 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Reiterates: Equal-Weight | $250 | $239.90 | +4.21% | 7 | Oct 9, 2024 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Reiterates: Overweight | $615 | $373.18 | +64.80% | 3 | Sep 5, 2024 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Reiterates: Overweight | $105 | $121.54 | -13.61% | 10 | Aug 6, 2024 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Reiterates: Equal-Weight | $320 | $291.06 | +9.94% | 9 | Jul 25, 2024 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintains: Equal-Weight | $95 → $122 | $172.49 | -29.27% | 10 | May 1, 2024 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Upgrades: Overweight | $92 | $22.06 | +317.14% | 9 | Jan 5, 2024 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Reiterates: Overweight | $280 | $377.66 | -25.86% | 9 | Nov 10, 2023 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Reiterates: Overweight | $95 | $3.52 | +2,598.86% | 4 | Jun 27, 2023 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintains: Equal-Weight | $2.25 → $1.5 | $4.82 | -68.88% | 3 | Nov 11, 2022 |
Ardent Health
May 20, 2025
Reiterates: Overweight
Price Target: $21
Current: $13.29
Upside: +58.07%
Addus HomeCare
Mar 12, 2025
Reiterates: Overweight
Price Target: $142
Current: $114.87
Upside: +23.62%
The Pennant Group
Mar 11, 2025
Reiterates: Overweight
Price Target: $38
Current: $28.88
Upside: +31.58%
Amedisys
Mar 4, 2025
Reiterates: Equal-Weight
Price Target: $101
Current: $97.97
Upside: +3.09%
Universal Health Services
Feb 28, 2025
Maintains: Equal-Weight
Price Target: $210 → $223
Current: $177.43
Upside: +25.68%
Alignment Healthcare
Jan 2, 2025
Reiterates: Overweight
Price Target: $17
Current: $13.80
Upside: +23.19%
Centene
Dec 13, 2024
Maintains: Equal-Weight
Price Target: $75 → $73
Current: $53.57
Upside: +36.27%
UnitedHealth Group
Dec 5, 2024
Maintains: Overweight
Price Target: $605 → $675
Current: $302.62
Upside: +123.05%
PACS Group
Nov 18, 2024
Maintains: Overweight
Price Target: $48 → $31
Current: $12.85
Upside: +141.25%
The Cigna Group
Nov 1, 2024
Reiterates: Overweight
Price Target: $410
Current: $330.00
Upside: +24.24%
Oct 28, 2024
Maintains: Overweight
Price Target: $163 → $167
Current: $153.79
Upside: +8.59%
Oct 22, 2024
Initiates: Overweight
Price Target: $21
Current: $21.18
Upside: -0.83%
Oct 9, 2024
Reiterates: Equal-Weight
Price Target: $250
Current: $239.90
Upside: +4.21%
Sep 5, 2024
Reiterates: Overweight
Price Target: $615
Current: $373.18
Upside: +64.80%
Aug 6, 2024
Reiterates: Overweight
Price Target: $105
Current: $121.54
Upside: -13.61%
Jul 25, 2024
Reiterates: Equal-Weight
Price Target: $320
Current: $291.06
Upside: +9.94%
May 1, 2024
Maintains: Equal-Weight
Price Target: $95 → $122
Current: $172.49
Upside: -29.27%
Jan 5, 2024
Upgrades: Overweight
Price Target: $92
Current: $22.06
Upside: +317.14%
Nov 10, 2023
Reiterates: Overweight
Price Target: $280
Current: $377.66
Upside: -25.86%
Jun 27, 2023
Reiterates: Overweight
Price Target: $95
Current: $3.52
Upside: +2,598.86%
Nov 11, 2022
Maintains: Equal-Weight
Price Target: $2.25 → $1.5
Current: $4.82
Upside: -68.88%